Aster Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Aster Capital Management's UTHR Position: Q3 2026 in Review
Aster Capital Management sold out of United Therapeutics (UTHR) in Q3 2026, closing a stake of 1,078 shares — an estimated $584K sold.
Aster Capital Management first reported a position in UTHR in Q3 2024 and held it in 8 quarters. The position peaked at $584K in Q2 2026. 841 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Aster Capital Management reported no remaining United Therapeutics position as of Q3 2026 after selling out during the quarter.
- Aster Capital Management sold 1,078 United Therapeutics shares in Q3 2026, an estimated $584K.
- Aster Capital Management first reported a position in United Therapeutics in Q3 2024 and held it in 8 quarters.
- Aster Capital Management's United Therapeutics position peaked at $584K in Q2 2026.
- 841 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.